Australia & New Zealand Spinal Implants and Devices Market

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.5.4. Impact Analysis
3.6. GOVERNMENT REGULATIONS

CHAPTER 4 AUSTRALIA & NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW
4.1.1. Market size and forecast
4.1.2. Spinal Implantations, By Type
4.2. SPINAL FUSION DEVICES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Spinal Fusion Device Implantations, By Type
4.2.5. Thoracolumbar Devices
4.2.5.1. Market size and forecast
4.2.5.2. Anterior Lumbar Plates
4.2.5.2.1. Market size and forecast
4.2.5.3. Lumbar Plates
4.2.5.3.1. Market size and forecast
4.2.5.4. Pedicle Screw
4.2.5.4.1. Market size and forecast
4.2.5.5. Rods
4.2.5.5.1. Market size and forecast
4.2.5.6. Hooks
4.2.5.6.1. Market size and forecast
4.2.5.7. Wires & Cables
4.2.5.7.1. Market size and forecast
4.2.5.8. Crosslinks
4.2.5.8.1. Market size and forecast
4.2.6. Cervical Fixation Devices
4.2.6.1. Market size and forecast
4.2.6.2. Anterior Cervical Plates
4.2.6.2.1. Market size and forecast
4.2.6.3. Hook Fixation Systems
4.2.6.3.1. Market size and forecast
4.2.6.4. Plates & Screws
4.2.6.4.1. Market size and forecast
4.2.6.5. Clamps
4.2.6.5.1. Market size and forecast
4.2.6.6. Wires
4.2.6.6.1. Market size and forecast
4.2.7. Interbody Fusion Devices
4.2.7.1. Market size and forecast
4.2.7.2. Non-Bone Interbody Fusion Devices
4.2.7.2.1. Market size and forecast
4.2.7.3. Bone Interbody Fusion Devices
4.2.7.3.1. Market size and forecast
4.3. NON-FUSION/MOTION PRESERVATION DEVICES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Motion Preservation Device Implantations, By Type
4.3.5. Dynamic Stabilization Devices
4.3.5.1. Market size and forecast
4.3.5.2. Interspinous Process Spacers
4.3.5.2.1. Market size and forecast
4.3.5.3. Pedicle Screw-Based Systems
4.3.5.3.1. Market size and forecast
4.3.5.4. Facet Replacement Products
4.3.5.4.1. Market size and forecast
4.3.6. Artificial Discs
4.3.6.1. Market size and forecast
4.3.6.2. Artificial Cervical Discs
4.3.6.2.1. Market size and forecast
4.3.6.3. Artificial Lumbar Discs
4.3.6.3.1. Market size and forecast
4.3.7. Annulus Repair Devices
4.3.7.1. Market size and forecast
4.3.8. Nuclear Disc Prostheses
4.3.8.1. Market size and forecast
4.4. VERTEBRAL COMPRESSION FRACTURE DEVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. VCF Device Implantations, By Type
4.4.5. Balloon Kyphoplasty Devices
4.4.5.1. Market size and forecast
4.4.6. Vertebroplasty Devices
4.4.6.1. Market size and forecast
4.5. SPINE BONE STIMULATORS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Spinal Bone Stimulator Implantations, By Type
4.5.5. Non-Invasive Spine Bone Stimulators
4.5.5.1. Market size and forecast
4.5.5.2. Pulsed Electromagnetic Field Device
4.5.5.2.1. Market size and forecast
4.5.5.3. Capacitive Coupling and Combined Magnetic Field Device
4.5.5.3.1. Market size and forecast
4.5.6. Invasive Spine Bone Stimulators
4.5.6.1. Market size and forecast
4.6. SPINE BIOLOGICS
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Spine Biologic Implantations, By Type
4.6.5. Spinal Allografts
4.6.5.1. Market size and forecast
4.6.5.2. Machined Bone Allograft
4.6.5.2.1. Market size and forecast
4.6.5.3. Demineralized Bone Matrix
4.6.5.3.1. Market size and forecast
4.6.6. Bone Graft Substitutes
4.6.6.1. Market size and forecast
4.6.6.2. Bone Morphogenetic Proteins
4.6.6.2.1. Market size and forecast
4.6.6.3. Synthetic Bone Grafts
4.6.6.3.1. Market size and forecast
4.6.7. Cell Based Matrix
4.6.7.1. Market size and forecast

CHAPTER 5 AUSTRALIA & NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY SURGERY

5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. OPEN SPINE SURGERY
5.2.1. Market size and forecast
5.3. MINIMALLY INVASIVE SPINE SURGERY
5.3.1. Market size and forecast

CHAPTER 6 AUSTRALIA & NEW ZEALAND SPINAL IMPLANTS AND DEVICES MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. AUSTRALIA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.3. NEW ZEALAND
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ALPHATEC HOLDINGS, INC.
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. EXACTECH, INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. JOHNSON & JOHNSON
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. GLOBUS MEDICAL, INC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. MEDTRONIC PLC
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. NUVASIVE, INC.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. ORTHOFIX INTERNATIONAL N.V.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. STRYKER CORPORATION
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. THERAKOS, INC.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments